Method for determining content and impurities of levocarnitine injection and use thereof

A technology for injection and impurities, applied in the determination of levocarnitine injection content and impurities, hydrophilic interaction chromatography determination of levocarnitine injection content and impurities, can solve the requirements of low separation limit and theoretical plate number Reduced, short life of the column and other problems, to achieve the effect of overcoming the hard-to-obtain

Active Publication Date: 2017-06-13
YANTAI UNIV
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The United States Pharmacopoeia selects the chromatographic column as an amino-bonded phase chromatographic column. In the method, the demand for the chromatographic column to be equilibrated for up to 3 hours before sa

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for determining content and impurities of levocarnitine injection and use thereof
  • Method for determining content and impurities of levocarnitine injection and use thereof
  • Method for determining content and impurities of levocarnitine injection and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0033] The following examples help to further understand the present invention, but the present invention is not limited to these contents.

[0034] A method for determining the content and impurities of levocarnitine injection by hydrophilic interaction chromatography.

[0035] 1 material preparation

[0036] Shimadzu LC-20A high performance liquid chromatography system (including LC-20AT pump; DGU-20A degasser; SIL-20A autosampler; CTO-10ASvp column thermostat; SPD-20A UV detector; Lab solution chromatography Workstation); WatersXBridge Amide chromatographic column (4.6mm × 250mm, 3.5μm); 1 / 10,000 electronic balance (AR1140, OhausCorp.Brook, NJ, USA); 1 / 100,000 electronic balance (MS105Du type, METTLER TOLEDO); Electronic pH meter (pHMeter PHS-3C, Shanghai Jingke Industrial Co., Ltd.); ultrasonic cleaner (SK250HP, Wuxi Jianyi Experimental Equipment Co., Ltd.).

[0037] The reference substance of levocarnitine was provided by China National Institutes for Food and Drug Cont...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a method for determining the content and impurities of a levocarnitine injection by hydrophilic interaction chromatography. A result of methodology validation shows that the method is high in degree of separation, has an accurate determination result, can be used for controlling relevant substances of the levocarnitine injection, and provides reference for increase of a quality standard of the levocarnitine injection. Meanwhile, the method can be used for determining the content and impurities of the levocarnitine injection.

Description

technical field [0001] This patent relates to a method for determining the content and impurities of levocarnitine injection, specifically a method for determining the content and impurities of levocarnitine injection by hydrophilic interaction chromatography, which belongs to the field of drug analysis. Background technique [0002] Levocarnitine, whose chemical name is (R)-3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanamine hydroxide, is an essential natural substance in the energy metabolism of mammals. The main function is to assist cells in lipid metabolism and energy production. [0003] E-4-(trimethylammonium)but-2-enoic acid ethyl ester (referred to as impurity A) is the main impurity and degradation product in levocarnitine, its structure contains a conjugated structure, and the response value is much greater than Levocarnitine, which needs to be quantified separately. [0004] The structural formulas of levocarnitine and its impurity A are as follows, [0005] ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N30/02
Inventor 许丽晓耿银银刘万卉
Owner YANTAI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap